Micron's third quarter is not a recovery quarter. It is the most profitable quarter in the company's history, and the margin sits roughly 31 percentage points above its own previous cycle peak — though note that comparison sets a quarterly margin against an annual one. Revenue reached $41,456 million against $9,301 million a year earlier, and operating income of $33,318 million produced an 80.4% operating margin — against a 49.3% peak in FY2018 and a 19.1% average across fiscal 2017 through fiscal 2025 (simple averages of annual GAAP operating margins, company annual reports). What makes the quarter worth reading closely is not the size of the number but its durability: management has begun converting spot pricing into multi-year take-or-pay contracts, and the terms of those contracts — not the current price of DRAM — will decide how much of this earnings power survives the next downturn.
1. Consolidated Balance Sheet
1-1. Major asset items
| Item | Aug 28, 2025 ($M) | May 28, 2026 ($M) | Change % |
|---|---|---|---|
| Cash and cash equivalents | 9,642 | 24,995 | +159.2% |
| Receivables | 9,265 | 31,025 | +234.9% |
| — of which trade receivables | 7,163 | 26,894 | +275.5% |
| Inventories | 8,355 | 8,567 | +2.5% |
| Property, plant, and equipment | 46,590 | 56,426 | +21.1% |
| Intangible assets | 453 | 473 | +4.4% |
| Total assets | 82,798 | 134,112 | +62.0% |
Total assets grew 62% in nine months. The balance sheet did not expand evenly, and the unevenness is the story.
Receivables rose 235%, which looks alarming until it is measured against sales. Days sales outstanding — how long the company waits to get paid — was essentially unchanged at 59.0 days, against roughly 58 days at the August 2025 fiscal year end ($7,163 million of trade receivables against $11.32 billion of fourth-quarter FY2025 revenue, per the FY2025 Form 10-K). The receivable build tracks revenue rather than outrunning it. Note also that $3,408 million of the receivable line is government incentives owed to Micron, not customer money. Trade receivables alone are $26,894 million.
Inventory is the sharpest signal. Total inventory rose just 2.5% while revenue rose 346%. Inside that number, finished goods fell 43.2%, from $1,094 million to $621 million, while work in process rose 8.7%. Finished goods now represent 8.8 days of cost of goods sold, down from 17.2 days. Micron is shipping product essentially as fast as it can finish it. The filing describes supply allocation decisions that "may impact certain customers and end markets" — the inventory line is what that sentence looks like in numbers.
Property, plant and equipment rose 21.1% to $56,426 million, but the forward-looking component matters more: construction in progress nearly doubled, from $5,518 million to $10,935 million. That is capacity being built for calendar 2027 and beyond, not capacity producing today's revenue.
Right-of-use assets from operating leases were roughly flat at $683 million against $736 million — immaterial to the picture.
Debt maturity profile. Micron prepaid aggressively during the period. Total borrowings fell to $5,722 million from $14,577 million. The remaining stack is long-dated and modest, with the 2032 Green Bonds carrying a 2.703% stated rate and a 2.77% effective rate, and the 2031 Notes at 5.300%. The revolving credit facility was voluntarily reduced from $3.50 billion to $2.00 billion on May 6, 2026, with nothing drawn. A company shrinking its own backstop credit line is signalling that it does not expect to need it.
1-2. Liability structure — financial vs operating
Financial debt fell 60.7%, from $14,577 million to $5,722 million. Against cash and marketable investments of $30,128 million, Micron now holds a net cash position of roughly $24.4 billion. The debt-to-equity ratio fell from 26.9% to 5.7%. On the covenant that governs the revolver — net debt to adjusted EBITDA, capped at 3.25 to 1.00 — the company has no meaningful exposure at present.
Operating liabilities tell a different story. Accounts payable and accrued expenses rose 60.9% to $15,521 million, of which $6,914 million relates to property, plant and equipment purchases — that is the capital programme, not trade credit. Other current liabilities rose 171.9% to $3,385 million, and the filing attributes $3.32 billion of it to "estimates of consideration payable to customers, including pricing adjustments and returns," up from $1.19 billion. That is a reserve held against revenue already booked.
The largest single liability move is easy to misread. Other noncurrent liabilities rose 391% to $7,086 million. The bulk of it is not customer deposits: the filing states that $5,790 million is income taxes payable, against $648 million at the August 28, 2025 fiscal year end. Customer deposits are in there, but small so far — of approximately $5 billion in remaining performance obligations under the strategic customer agreements, only $422 million had been recognised as contract liabilities at the quarter end. That balance is set to grow sharply.
Total liabilities rose just 16.6% while total assets rose 62.0%.
1-3. Capital structure
Paid-in capital (common stock plus additional capital) rose modestly to $14,570 million from $13,466 million. Retained earnings rose 94.9%, from $48,583 million to $94,682 million. Total equity rose 86.0% to $100,724 million, and the equity ratio improved from 65.4% to 75.1%.
Almost the entire increase in equity is retained profit. Treasury stock moved from $(7,852) million to $(8,502) million, a $650 million buyback under the repurchase programme. Accumulated other comprehensive loss narrowed to $(26) million from $(32) million and is immaterial. This is a balance sheet being rebuilt by earnings, not by issuance and not distorted by mark-to-market noise.
2. Consolidated Statement of Operations
2-1. Core profitability
| Item | Q3 FY2025 ($M) | Q2 FY2026 ($M) | Q3 FY2026 ($M) | YoY change |
|---|---|---|---|---|
| Revenue | 9,301 | 23,860 | 41,456 | +345.7% |
| Cost of goods sold | 5,793 | 6,105 | 6,400 | +10.5% |
| Gross margin | 3,508 | 17,755 | 35,056 | +899.3% |
| Gross margin (%) | 37.7% | 74.4% | 84.6% | — |
| Research and development | 965 | 1,250 | 1,316 | +36.4% |
| Operating income | 2,169 | 16,135 | 33,318 | +1,436.1% |
| Operating margin (%) | 23.3% | 67.6% | 80.4% | — |
| Net income | 1,885 | — | 28,243 | +1,398.3% |
| Net margin (%) | 20.3% | — | 68.1% | — |
| Diluted EPS ($) | 1.68 | — | 24.67 | +1,368.5% |
Every figure above is US GAAP, as reported in the Form 10-Q. The 10-Q carries no adjusted earnings measure, so nothing in this table requires reconciliation — though Micron does publish non-GAAP figures in its quarterly earnings release, and those are not the numbers used here.
The mechanism is price, not volume. Revenue rose 346% year over year while cost of goods sold rose only 10.5%. DRAM average selling prices rose in the "low-260% range" — that is, roughly 3.6 times the year-ago level — with bit shipments up only in the "low-20% range." NAND prices rose in the "low-310s%" range on low-double-digit bit growth. Micron sold modestly more memory at radically higher prices.
The sequential quarter shows the same pattern still accelerating. Revenue rose 73.7% from Q2, while cost of goods sold rose just 4.8%, from $6,105 million to $6,400 million. DRAM sales rose 67% on a low-60% price increase and only low-single-digit bit growth; NAND sales rose 99% on a mid-80% price increase and high-single-digit bit growth. The operating margin gained nearly 13 percentage points in a single quarter, from 67.6% to 80.4%. The pricing move had not flattened by the end of the period.
Operating leverage — how much profit moves for a given move in sales — is extreme. Operating income grew 1,436% on 346% revenue growth, a ratio of 4.15 times. That ratio is an after-the-fact arithmetic artifact of a price spike against a near-fixed cost base, not a stable elasticity, and it should not be run in reverse as a forecast. What is durable is the underlying structure: the cost base barely moves, so margin swings violently in both directions. It is the same fixed-cost arithmetic that produced a $5,745 million operating loss in FY2023.
Operating income contains no impairment or restructuring charges and is clean, recurring operating income. Below the operating line, however, there is a one-off: other non-operating expense of $(321) million is more than fully explained by a $323 million loss on the early prepayment of debt (Note 9 discloses a $500 million prepayment loss for the nine months). Excluding that charge, the line is a marginal positive of about $2 million. Separately, the company earned $215 million of interest income; interest expense on the remaining $5,722 million of borrowings — reduced by 60.7% during the period but not retired — partially offset that income.
EPS growth of 1,368% slightly lagged net income growth of 1,398%. The difference is dilution, not buybacks — diluted share count rose to 1,145 million from 1,125 million as equity compensation vested. The $650 million repurchase was too small to offset it.
2-2. Fixed versus variable cost
The cost base barely moved, which is what a fixed-cost manufacturer looks like at the top of a cycle.
| Cost line | FY2025 ($M) | FY2026 ($M) | Change % |
|---|---|---|---|
| Cost of goods sold (Q3) | 5,793 | 6,400 | +10.5% |
| Research and development (Q3) | 965 | 1,316 | +36.4% |
| Selling, general, administrative (Q3) | 318 | 407 | +28.0% |
| Depreciation and amortisation (nine months) | 6,203 | 6,862 | +10.6% |
Note the depreciation row is a nine-month figure; the three cost lines above it are single-quarter. Depreciation, the single largest fixed cost in a fab business, rose only 10.6% over nine months. R&D rose 36.4%, driven by higher volumes of development wafers and compensation — a deliberate increase, not an inflationary one. SG&A rose 28.0% on compensation.
One US GAAP point matters for cross-border comparison. Micron expenses all research and development immediately; it cannot capitalise development costs the way an IFRS reporter may. Micron's $1,316 million quarterly R&D charge sits entirely in operating income. Comparing this operating margin directly against an IFRS-reporting competitor that capitalises part of its development spend overstates Micron's relative disadvantage.
3. Consolidated Statement of Cash Flows
| Item (nine months) | FY2025 ($M) | FY2026 ($M) | Change |
|---|---|---|---|
| Operating cash flow | 11,795 | 45,702 | +287.5% |
| Investing cash flow | (8,889) | (19,688) | — |
| Financing cash flow | 214 | (10,646) | — |
| Capital expenditure | (10,199) | (19,602) | +92.2% |
| Free cash flow | 1,596 | 26,100 | +1,535% |
| Ending cash (incl. restricted) | 10,169 | 25,022 | +146.1% |
Free cash flow — operating cash flow less capital expenditure — reached $26,100 million against $1,596 million. All ratios in this section are computed on a nine-month basis, against nine-month revenue of $78,959 million, not against the $41,456 million single-quarter figure used in Section 2. On that basis the free cash flow margin is 33.1%. Adding $2,989 million of government incentive proceeds received during the period lifts cash generation further.
Quality of earnings deserves care here. Nine-month operating cash flow divided by nine-month net income is 0.97, down from 2.21 a year earlier. A reading below 1.0 usually signals profit that has not converted to cash. In this case two specific items explain it, and they point in opposite directions.
The drag is receivables, which consumed $19,953 million of cash. As noted, days sales outstanding was essentially unchanged, so this is growth absorbing working capital rather than customers failing to pay.
The offset is less comfortable. Other noncurrent liabilities contributed $5,203 million to operating cash flow, and the filing shows this is almost entirely income taxes payable, which rose to $5,790 million from $648 million. Roughly $5.1 billion of reported operating cash flow is tax that has been charged against profit but not yet paid. Strip it out and nine-month operating cash flow is approximately $40.6 billion and free cash flow approximately $21.0 billion. Both remain well above any prior-cycle comparison.